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ABSTRACT
Objective: This study evaluated the impact of clinical pharmacist-led intervention in health knowledge and medication adherence of Asthma and 
chronic obstructive pulmonary disease (COPD) patients.
Methods: Questionnaires were designed to assess Health knowledge for Asthma and COPD separately. Medication adherence was measured by using 
the Morisky Medication Adherence Scale-8. Pre-counseling patient responses were recorded. Patient counseling was given regarding the disease 
condition, medications, and medication use at baseline visit. Patient responses were re-measured upon follow-up visit. The data extracted were 
tabulated, statistically analyzed and the results were obtained.
Results: A total of 141 patients completed the study. Before counseling, the mean (±standard deviation) of knowledge and adherence levels were 
found to be 8.51±3.36 and 5.01±2.11, respectively. After counseling, they increased up to 12.72±2.16 for knowledge (p<0.0001) and 6.60±1.35 
(p<0.0001) for medication adherence. The majority of subjects had about 11–30% increase in knowledge as well as medication adherence. Male 
patients were more adherent to their medication regime than females.
Conclusion: The study demonstrates the positive impact of education and counseling provided by a clinical pharmacist in achieving better therapeutic 
outcomes – through improvement in medication adherence and health knowledge. In conclusion, continuous education programs and patient 
counseling should be conducted for chronic diseases to reiterate the importance of medication adherence and, in turn, prevent recurrences, arrest 
disease progression, minimize hospitalization, and ultimately improve quality of life.
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INTRODUCTION
Medication non-adherence in chronic conditions such as Asthma and 
chronic obstructive pulmonary disease (COPD) is a recognized public 
health problem [1]. The existing literature suggests that a structured 
pharmaceutical care plan and clinical pharmacist intervention can help 
patients in achieving desired health outcomes. Pharmacist intervention 
is essential in chronic diseases, especially in chronic respiratory 
diseases, since the success of treatment not only depends on the type 
of drugs but also on the medication-taking techniques and adherence.
Medication adherence usually refers to whether patients take their 
medications as prescribed (e.g., twice daily) as well as whether they 
continue to take a prescribed medication [2]. Patient counseling deals with 
providing information to the patients regarding their medications in simple 
Layman’s language. It may be defined as providing medication information 
orally or in written form to the patients or to their representative.
The objective of this study was to evaluate and measure the difference in 
health knowledge of the patients and medication adherence in Asthma and 
COPD patients – post-counseling. The study rationale is to reiterate that 
medication adherence improvements are brought about by pharmacist 
led intervention like patient counselling, especially with respect to the 
type of healthcare setting and patient population taken in our study.
METHODS
A prospective cross-sectional observational study was conducted 
over a period of 6 months in the Department of Pulmonary Medicine 
(chest outpatient) at a Secondary Care Hospital located in Nacharam, 
Hyderabad, Telangana.
During the study, patients labeled as suffering from Asthma and COPD and 
seeking treatment for the same; >18 years of age; willing to participate 
in the study as well as visiting chest outpatient departments were 
included in the study. Non-cooperative patients, patients with multiple 
co-morbidities, pediatric, and pregnant population and who were unable 
to answer or complete data collection forms were excluded from the 
study. During the study period, the data were collected twice a week, 
i.e., when the chest outpatient services were open. Questionnaires were 
designed to assess health knowledge (disease knowledge and medication 
knowledge) and medication adherence, for Asthma and COPD. Health 
knowledge questionnaires were prepared for Asthma and COPD that 
included questions on present diagnosis, causes, symptoms, drug 
names, drug regimen, inhaler use, etc. The questionnaire was validated 
by the physician and a pilot study. Morisky Medication Adherence Scale 
(MMAS-8) was used to measure the medication adherence in both Asthma 
and COPD patients. Patient counseling sessions involved educating the 
patient about the disease, symptoms, risk factors and their management, 
types of drugs used in the treatment, gross mechanism of  actions, drug 
regimen, inhaler use, and side effects. Pre-approved pictorial patient 
information leaflets were designed and distributed to all the patients. 
The data collected pre- and post-counseling was managed and analyzed 
using the software MS Excel 2016. Data were analyzed for means and 
percentage increase in health knowledge and medication adherence 
(using MS Excel 2016) to determine the post-counseling effects. The 
statistical significance was calculated using SPSS 9.0.
Ethical considerations
All interventions in this study were non-invasive, were done after carefully 
assessing the need for intervention and implementing them with prior 
approval from the hospital’s management and institutional ethical committee.
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RESULTS
The sociodemographic distribution included a total of 150 subjects 
formed the study population, of which nine were dropped out because 
of lack of follow up (n=141). Disease-wise distribution showed that 
Asthma and COPD patients were 109 and 32 in number, respectively, 
which accounted for 77.30% and 22.69% of the total population, 
respectively (Table 1).
Based on the gender-wise distribution of population, the number of 
males was found to be 45 in number suffering from Asthma and 31 
suffering from COPD, whereas females were 64 and 1, respectively. The 
majority of Asthmatics were females, while in COPD, the male gender 
was dominant (Table 2).
The whole population was distributed among the following age ranges, 
i.e., <30, 31–50, 51–70, and >71. The number of subjects falling into the 
above-mentioned ranges having Asthma was 13, 61, 31, and 4, whereas 
subjects with COPD were 0, 5, 25, and 2 in number, respectively. Asthma 
was found to be more among the age group 31–50 years, while COPD 
was most among the age group 51–70 years, forming 43.26% and 
17.73% of the total population, respectively (Table 3).
A family history of the disease in our study population was found to 
be 40 and 69 subjects of Asthma with and without any family history, 
respectively. In the subjects with COPD, no family history of the disease 
was found. The majority of the population, i.e., 101 of 141, was found to 
have no family history of their disease (Table 4).
Study population’s smoking habit showed seven smokers and 102 
non-smokers suffering from Asthma, whereas 26 smokers and six non-
smokers in COPD. The majority of the population were non-smokers, 
with only 33 subjects having a smoking habit currently (Table 5).
All the subjects were categorized, education-wise, as illiterate, 
primary, middle, secondary, higher secondary/intermediate, 
technical/non-technical diploma, and graduate and above with the 
number of subjects falling in each category was 55, 11, 12, 28, 12, 4, 
and 19, respectively. The majority of the population was found to be 
“illiterate” followed by a significant number who completed secondary 
schooling (Table 6).
The baseline data on medication adherence showed 85 subjects having 
low medication adherence. The post-counseling (follow-up) session 
showed that 48 of those lowly adherent patients have effectively 
transformed into moderate to highly adherent individuals. Moreover, 
the remaining 37 subjects with low adherence had a mean percentage 
increase of 27.87% in their adherence levels. The medication adherence 
among males and female were found to be 5.24 and 4.73 pre-counseling 
and 6.67 and 6.52 post-counseling, respectively. The male patients were 
more adherent than females (Table 7).
The average knowledge and medication adherence scores were 
calculated to estimate the levels of the same before and after patients 
were given counseling. It was found that the mean (with standard 
deviation) of knowledge and adherence levels was found to be 
8.51±3.36 and 5.01±2.11 before counseling which increased up to 
12.72±2.16 for knowledge (p<0.0001) and 6.60±1.35 (p<0.0001) 
for medication adherence, respectively, after counseling the subjects 
(Table 8) (Graph 1).
Each subject fell under a range of categories for percentage increase 
in knowledge and medication adherences which were created based 
on the difference between their scores before and after counseling. 
The ranges of the categories were ≤ng 11–30%, 31–50%, 51–70%, and 
>70%, with the number of subjects in each category being 31, 90, 18, 2, 
Table 1: Disease-wise distribution of Asthma and COPD
Disease No. of subjects n (%)
Asthma 109 (77.30)
COPD 32 (22.69) 
Total n (%) 141 (99.99) 
COPD: Chronic obstructive pulmonary disease 
Table 2: Gender-wise distribution of Asthma and COPD
Gender Male n (%) Female n (%) Total n (%)
Asthma 45 (31.91) 64 (45.39) 109 (77.30)
COPD 31 (21.98) 1 (0.70) 32 (22.69)
Total n (%) 76 (53.90) 65 (46.09) 141 (99.99) 
COPD: Chronic obstructive pulmonary disease
Graph 1: Mean knowledge and medication adherence scores 
pre- and post-counseling
Graph 2: Categorical increase in the percentage of knowledge and 
medication adherence among the study subjects post-counseling
Table 3: Age-wise distribution of Asthma and COPD 
Age <30 n (%) 31–50 n (%) 51–70 n (%) >71 n (%) Total n (%)
Asthma 13 (9.21) 61 (43.26) 31 (21.98) 4 (2.83) 109 (77.30)
COPD NA 5 (3.54) 25 (17.73) 2 (1.41) 32 (22.69) 
Total n (%) 13 (9.21) 66 (46.80) 56 (39.71) 6 (4.25) 141 (99.99) 
COPD: Chronic obstructive pulmonary disease
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Table 4: Family history of Asthma and COPD
Family history Present n (%) Absent n (%) Total n (%)
Asthma 40 (28.36) 69 (48.93) 109 (77.30)
COPD 0 (0) 32 (22.69) 32 (22.69)
Total n (%) 40 (28.36) 101 (71.62) 141 (99.99)
COPD: Chronic obstructive pulmonary disease
Table 5: Distribution based on smoking habit of the subjects
Smoker n (%) Non-smoker n (%) Total n (%)
Asthma 7 (4.96) 102 (72.34) 109 (77.30) 
COPD 26 (18.43) 6 (4.25) 32 (22.69)
Total n (%) 33 (23.40) 108 (76.59) 141 (99.99) 
COPD: Chronic obstructive pulmonary disease
Table 6: Education-wise demographic distribution





Higher secondary/intermediate 12 (8.51)
Technical/non-technical diploma 4 (2.83)
Graduate and above 19 (13.47)
Total n (%) 141 (100)







Table 8: Mean knowledge and medication adherence scores pre- 
and post-counseling






*p<0.0001, S.D: Standard deviation, n=141
Table 9: Categorical increase in the percentage of knowledge and medication adherence among the study subjects post-counseling
% increase No. of subjects n (%)
<10% 11–30% 31–50% 51–70% >70% Total n (%)
Knowledge 31 (21.98) 90 (63.82) 18 (12.76) 2 (1.41) 0 (0) 141 (99.97) 
Medication adherence 45 (31.91) 56 (39.71) 33 (23.40) 7 (4.96) 0 (0) 141 (99.98) 
and 0, respectively. The majority of subjects fell into 11–30% increase 
in knowledge as well as medication adherence (Table 9) (Graph 2).
DISCUSSION
Our study aimed at improving medication adherence and health 
knowledge through patient counseling – a clinical pharmacist 
intervention that evidently can help patients in achieving desired 
health outcomes. Pharmacist intervention in this study focused 
on providing disease and medication knowledge and improving 
medication utilization techniques. Therefore, medication adherence 
changes pre- and post-counseling are believed to be the results of the 
interventions applied.
The majority of females suffered from Asthma while in the COPD 
category, the male gender was dominant. A study conducted by 
Shamkuwar et al. [3] showed a gender-wise distribution of 80 (51.9%) 
male patients and 74 (48.1%) of female patients in Asthma, on the other 
hand, a study conducted by Faheemuddin et al. [4] showed a greater 
number of males than females in COPD.
Asthma was found to be more in the age group of 31–50 years, while 
COPD was found most in the age group of 51–70 years, forming 43.26% 
and 17.73% of the total population, respectively. Faheemuddin et al. [4] 
observed most patients of the age group of 61–80 years affected with 
COPD. Adherence to respiratory therapy was associated with age which 
was evidenced by a study conducted by Agh et al. [5].
With respect to habit-wise distribution, most of our study population 
(108) was non-smokers, with only 33 subjects being smokers. On the 
contrary, there was a high percentage of smokers in both intervention 
28 (93.3%) and control 25 (83.3%) groups of the study conducted by 
Faheemuddin et al. [4].
Agh et al. [5] associated adherence to respiratory therapy with current 
smoking status (p<0.005) in their study. Therefore, the positive outcomes 
of this study could be attributed to the non- smoking status of the majority.
A study conducted by Wahyuni et al. [6] showed an average difference 
in the value of adherence based on education and employment (<0.05). 
In this study, the majority of the population was found to be illiterately 
followed by a significant number of subjects completing secondary 
schooling. The highest education adherence was shown by patients 
with college education level and lowest adherence was shown by 
patients with primary school education.
According to a study by Prabhakaran et al. [7], there were significant 
improvements in the knowledge of Asthma and medications, self-
reported compliance to the treatment regimen, and improvement in 
inhaler technique because of post-pharmacist interventions. Kovacevic 
et al. [8] showed significantly improved patients’ knowledge of Asthma 
and medications as well as the adherence level with a pharmacist-
delivered self-management education. Similarly, our study showed a 
significant improvement in patient’s health knowledge and medication 
adherence upon receiving counseling.
Overall improvement in both these parameters post-counseling was 
evidenced by a mean percentage increase of 21.21% and 20.75% in 
health knowledge and medication adherence, respectively.
In addition, the positive impact of patient counseling on medication 
adherence was found by a drop in the number of less adherent subjects 
from 85 to 37 and a mean percentage increase of 27.87% in medication 
adherence score in subjects who were less adherent post-counseling.
Limitations
This study has a limited population size because only those patients 
diagnosed through a specific health system were enrolled into the study. 
The procedural, analytical, and recording errors as well as interviewer 
bias were not taken into consideration.
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CONCLUSION
The study focuses on the positive impact of health education and counseling 
provided by a clinical pharmacist in achieving better therapeutic outcomes 
through improvement in medication adherence and health knowledge. It 
signifies the regular implementation of patient counseling as a mandatory 
clinical pharmacy service in the management of chronic diseases such as 
Asthma and COPD for improving quality of life. The study demonstrated 
the role of patient counseling along with other clinical pharmacy services 
as part of routine bedside and outpatient consultations which proved to 
be a major game changer in achieving patient-centric treatment goals. 
Continuous patient education programs and counseling services in a 
general healthcare setting is gaining momentum with both patients and 
health-care providers benefitting from them. With patient counseling 
covering the entire spectrum of activities under its umbrella, from 
evaluating social domestic profile to identifying major factors influencing 
medication-taking behavior and adherence, and conducting counseling 
sessions to meet individual needs, it is an undisputable solution for 
problems such as non-adherence and other drug-related problems. The 
study also has a futuristic view of analyzing the role and efficiency of 
different patient education tools and counseling aids in improving patient 
compliance and optimizing therapeutic outcomes.
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